{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T01:51:57Z","timestamp":1776909117476,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":1359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/gim.2017.133","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T11:01:42Z","timestamp":1508410902000},"page":"524-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["A cross-sectional quantitative analysis of the natural history of Farber disease: an ultra-orphan condition with rheumatologic and neurological cardinal disease features"],"prefix":"10.1016","volume":"20","author":[{"given":"Matthias","family":"Zielonka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven F.","family":"Garbade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"K\u00f6lker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg F.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/gim.2017.133_bb0010","author":"Sugita"},{"key":"10.1038\/gim.2017.133_bb0015","author":"Koch"},{"key":"10.1038\/gim.2017.133_bb0020","unstructured":"Levade T, Sandhoff K, Schulze H, Medin JA. 143: acid ceramidase deficiency: Farber lipogranulomatosis In: Valle D (ed). The Online Metabolic and Molecular Bases of Inherited Disease 2017. http:\/\/ommbid.mhmedical.com\/content.aspx?bookid=971&sectionid=62643272. Accessed 10 April 2017."},{"key":"10.1038\/gim.2017.133_bb0025","author":"Farber"},{"key":"10.1038\/gim.2017.133_bb0030","unstructured":"Orphanet Report Series. Prevalence of rare diseases: Bibliographic data. November 2016, no. 1, June 2016; http:\/\/www.orpha.net\/orphacom\/cahiers\/docs\/GB\/Prevalence:of_rare_diseases_by_alphabetical_list.pdf. Accessed 1 March 2017."},{"key":"10.1038\/gim.2017.133_bb0035","unstructured":"European Medicines Agency. Public summary of opinion on orphan designation. Recombinant human acid ceramidase for the treatment of Farber disease, 2014. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Orphan_designation\/2014\/03\/WC500164316.pdf. Accessed 1 March 2017."},{"key":"10.1038\/gim.2017.133_bb0040","unstructured":"US Food and Drug Administration. Search Orphan Drug Designations and Approvals, 2017. https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/. Accessed 1 March 2017."},{"key":"10.1038\/gim.2017.133_bb0045","author":"Mechler"},{"key":"10.1038\/gim.2017.133_bb0050","author":"Zielonka"},{"key":"10.1038\/gim.2017.133_bb0055","author":"von Elm"},{"key":"10.1038\/gim.2017.133_bb0060","author":"Hothorn"},{"key":"10.1038\/gim.2017.133_bb0065","author":"Kahle"},{"key":"10.1038\/gim.2017.133_bb0070","author":"Sidransky"},{"key":"10.1038\/gim.2017.133_bb0075","author":"Cappellari"},{"key":"10.1038\/gim.2017.133_bb0080","author":"Yeager"},{"key":"10.1038\/gim.2017.133_bb0085","author":"Jarisch"},{"key":"10.1038\/gim.2017.133_bb0090","author":"Torcoletti"},{"key":"10.1038\/gim.2017.133_bb0095","author":"Ramsubir"},{"key":"10.1038\/gim.2017.133_bb0100","author":"Walia"},{"key":"10.1038\/gim.2017.133_bb0105","author":"He"},{"key":"10.1038\/gim.2017.133_bb0110","author":"Ries"},{"key":"10.1038\/gim.2017.133_bb0115","author":"van Karnebeek"},{"key":"10.1038\/gim.2017.133_bb0120","author":"Kastner"},{"key":"10.1038\/gim.2017.133_bb0125","author":"Katz"},{"key":"10.1038\/gim.2017.133_bb0130","unstructured":"US Food and Drug Administration. Center for Drug Evaluation and Research. Guidance for Industry and FDA Staff: Qualification Process for Drug Development Tools, 2014. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM230597.pdf. Accessed 19 June 2017."},{"key":"10.1038\/gim.2017.133_bb0135","author":"Prentice"},{"key":"10.1038\/gim.2017.133_bb0140","author":"Schiffmann"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/gim2017133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gim2017133","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021018402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021018402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/gim.2017.133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/gim2017133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:47:24Z","timestamp":1761097644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360021018402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1098360021018402"],"URL":"https:\/\/doi.org\/10.1038\/gim.2017.133","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cross-sectional quantitative analysis of the natural history of Farber disease: an ultra-orphan condition with rheumatologic and neurological cardinal disease features","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/gim.2017.133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics","name":"copyright","label":"Copyright"}]}}